Hershey Presents at Goldman Sachs Forum: Reaffirms Recovery Path Amid Margin Squeeze

What happened

Hershey management presented at the Goldman Sachs Global Staples Forum, reaffirming their strategy to navigate severe cocoa-driven margin compression through pricing, productivity (AAA), and portfolio expansion into salty snacks. They reiterated that 2025 gross margins are expected to contract 650-700 bps, but they anticipate a return to 'algorithmic' growth in 2026 as cocoa costs normalize and cost savings materialize. However, the market has already priced in this recovery, with the stock trading at ~28x EPS and ~45% above a conservative DCF estimate, leaving a thin margin of safety. New CEO Kirk Tanner highlighted the integration of LesserEvil and continued share gains in salty snacks, but risks remain from sustained commodity volatility, tariff costs, and potential volume elasticity from aggressive pricing. The presentation introduced no material new information but underscored management's confidence in the long-term franchise strength despite near-term headwinds.

Implication

For investors, the Goldman Sachs presentation underscores that management is firmly committed to its margin recovery strategy, but the stock's premium multiple (28x P/E) leaves little room for error. The near-term earnings trough is well understood, and any disappointment in cocoa normalization, cost savings, or consumer elasticity could trigger multiple compression. The key is to monitor quarterly volume and margin trends—if Hershey can demonstrate a credible path back to pre-shock margins, the current price might be justified; if not, downside risk is significant. Given the DCF anchor around $129, patient investors should wait for a pullback or clearer proof of structural margin improvement before initiating a position. The thesis remains one of high quality but limited near-term upside potential at current levels.

Thesis delta

The Goldman Sachs presentation does not alter the investment thesis—Hershey remains a high-quality franchise facing a cyclical margin squeeze with a credible recovery plan. However, the stock's elevated valuation relative to intrinsic value (45% above DCF) and the lack of new incremental positive catalysts mean the risk/reward is still unattractive for value-oriented investors. The focus should remain on monitoring real-time margin and volume data rather than management's forward-looking statements.